Arteriovenous Malformation Market Research Report - Forecast till 2030

Arteriovenous Malformation Market research report: by type (true arteriovenous malformation), diagnosis (physical examination, brain scans) treatment (endovascular embolization, neurosurgery), end user (hospitals & clinics) - Forecast till 2030

ID: MRFR/LS/3656-HCR | | Region: Global | 100 Pages         

Arteriovenous Malformation Market Speak to Analyst Request a Free Sample

Arteriovenous Malformation Market Overview:


The arteriovenous Malformation Market is anticipated to reach USD 4,563.64 Million by 2030 at 6.1% CAGR during the forecast period 2022-2030. Arteriovenous malformations (AVMs) can be understood as an abnormal tangle of a blood vessel that connects the arteries and veins. This connection disrupts the normal blood flow and oxygen circulation within the human body. When AVMs occur in any part of the human body, the surrounding tissues may not be able to get enough oxygen, and hence, the affected vein and arteries get weakened and ruptured. If AVMs are tangled are in the brain and ruptured, it may lead to bleeding in the brain which leads to the major connection of hemorrhage, strokes, or brain damage. AVMs can occur anywhere within the human body but majorly they are commonly found in the brain and spine.


COVID 19 Analysis


The COVID-19 pandemic has broken the web and market drifts and has circled new freedoms and difficulties. The pandemic is a unique worldwide general wellbeing crisis. The appearance of the pandemic has influenced pretty much every industry, and the positive and negative impacts are projected to affect the business development during the ongoing forecast period that will end in 2030. The exploration expert's continuous examination intensifies their exploration system to guarantee the consideration of fundamental COVID-19 issues and possible ways ahead. The report examines that the episode of the pandemic has constrained individuals to achieve an adjustment of their way of life and purchaser inclinations. The pandemic has additionally constrained the worldwide legislatures and public area to make significant strides like lockdown and severe measures that will affect the market and the interest that may bring about misfortunes during the estimated time frame that will end in 2030.


The public authority and arteriovenous Malformation Market players are understanding the need to get back to business as usual to keep the market working with the rising rivalry in the worldwide market premises. The arteriovenous malformation market patterns are relied upon to ascend with the improved innovative work drives that are winning in the worldwide market premises during the term of the ongoing forecast period of 2022-2030.


Market Dynamics


Drivers


There has been an increasing prevalence of neurological/brain disorders like arteriovenous malformation amongst others like epilepsy. There is a rising need for better treatment for such rare diseases. Hence, there is an increasing investment of biotechnology and pharmaceutical industries in research and development, and the availability of funds is likely to drive the growth of the arteriovenous Malformation Market during the forecast period that will be ending in 2030. Moreover, there has been increasing government support for research and development sectors that are supporting changing lifestyles, and rapid development in technology. These factors are expected to fuel the arteriovenous Malformation Market growth during the forecast period that will end in 2030.


Restraints


However, the arteriovenous Malformation Market size is witnessing the birth of certain factors that might hamper the market from growing during the forecast period of 2022-2030. There has been a higher cost associated with the treatment procedure and hence, this is a major fact that might be responsible for slowing the market growth during the forecast period of 2022-2030.


Technology Analysis


However, the arteriovenous Malformation Market is witnessing an increase in the company initiatives to provide better treatment and rising investment by biotechnology and pharmaceutical industries in the research and development activities in the global market premises. This is driving the global arteriovenous Malformation Market share from 2022 through 2030. Moreover, the technological advancements in the treatment and diagnosis along with the favorable reimbursement policies also boost up the market growth, as forecasted by the industry experts and business chiefs for the ongoing forecast period that is likely to be ending in 2030.


Study Objectives



  • The worldwide arteriovenous malformation market report is concentrated to have a profound investigation of the worldwide market works previously, then after the fact the novel Covid had hit the global market scale. The report plans to have a thought regarding the market elements like the chances and drivers that will help the market during the estimated time frame that will end in 2030. The arteriovenous Malformation Market report additionally means fostering comprehension of the limitations that may challenge the market from developing according to the forecasts.

  • The market report additionally examines the premise of the worldwide market division through which the market is working in a progression of worldwide areas for meeting the rising necessities of the interest group that is spread in the noticeable spots for the market and consequently, assist the market with developing per the potential income that has been estimated for the period that will end in 2030.

  • The arteriovenous Malformation Market report expects to have a thought regarding the rising business sector rivalry that is a consequence of the patterns and advancements that have been in the method of rising and extension in the worldwide business during the ongoing forecast period and further, help the financial backers settle on better choices.


Segment Overview


The AVM Market is witnessing the market scenarios and trends that support a substantial rise in the demand for the market expansion and availability in various global locations during the forecast period. The market segmentation is proof that the market is likely to function well and cater to the rising needs of the target audience. The segments are mentioned as follows:


Based on the market types


It is segmented based on the type and includes true arteriovenous malformation, occult or cryptic AVM or cavernous malformations, venous malformation, hemangioma, and dural fistula.


Based on the diagnosis


The AVM Market has been segmented based on diagnosis and includes a physical examination, blood test, brain scans, and others. Brain scan segment has further been segmented into computerized tomography (CT) scan, Magnetic Resonance Imaging (MRI), magnetic resonance angiography (MRA), and electroencephalography (EEG).


Based on the treatment


The arteriovenous malformation market is segmented based on the treatment and includes endovascular embolization, neurosurgery, and others.


Based on the market end-user


The market is segmented into hospitals and clinics, research laboratories amongst others.


Regional Analysis


The arteriovenous malformation market has been segmented based on geographical regions and is functional in five major regions across the globe. The North American region is likely to dominate the global arteriovenous malformation market owing to the huge presence and functioning of the patient population alongside the rising ability for high health care spending. The increasing government support for research & development is also helping the global market.    


Europe holds the second-largest share in the global market as per the predictions for the forecast period. The increased focus of various public and government agencies on treating various brain disorders or brain injuries inclusive of epilepsy and depression will have a positive impact on the growth of the European market amid the forecast period. The growing degree of public awareness will boost the adoption of these devices in the European market amid the forecast period.


Competitive Landscape


The rising market competition is a result of the following market players:



  • Toshiba Medical Systems Corporation (Japan)

  • Fujifilm Holdings (Japan)

  • Carestream Health (U.S.)

  • Electrical Geodesics Inc. (U.S.)

  • Nihon Kohden Corporation (Japan)


Recent Developments



  • The Asian Pacific region and country-wise market players are projected to emerge as the fastest-growing arteriovenous malformation market across the globe amid the rising market competition. Japan holds a major market share for being one of the most prominent places as the regional market due to the increasing availability of technology and huge healthcare spending owing to the rise in the disposable income of people in the APAC region.

  • The Middle East and Africa were holding the least share of the global market due to the limited availability of medical facilities during the historic forecast period that had ended in 2019. The countries, as a part of the region like UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East & African market for the ongoing forecast period of 2022-2030.

  • The African region is expected to witness a moderate degree of growth owing to the rising developments that have been undertaken by the prominent industry players which is a result of the rising funds and investments.


Report Overview


The arteriovenous malformation market report helps in understanding the market patterns that are likely to gain momentum in the ongoing forecast period of 2022-2030. The market report helps the potential investors and buyers understand the scenarios so that they can invest accordingly. The market report also discusses the impact of the pandemic outbreak on the market during the period that ends in 2030.


 



Report Scope:

Report Attribute/Metric Details
  Market Size   2030:USD 4,563.64 Million
  CAGR   6.1% (2022-2030)
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2020
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Types, Diagnosis, Treatment, and End user
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Toshiba Medical Systems Corporation (Japan), Carestream Health (U.S.), Nihon Kohden Corporation (Japan), Electrical Geodesics Inc. (U.S.), Fujifilm Holdings (Japan), GE Healthcare (U.S.), Siemens Healthcare(U.S.), Philips Healthcare (U.S.), Shimadzu Corporation (Japan), Masimo Corporation (U.S.), Hologic (U.S.), Esaote (Italy), and others
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • Increasing prevalence of brain diseases/disorders
  • Increasing investment by biotechnology and pharmaceutical industries in R&D
  • Rising need for the better treatment methods


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    Arteriovenous malformation market is expected to exhibit a CAGR of 6.10% from 2022 to 2030.

    Rising prevalence of strokes and neurological disorders and investments by major biotechnology companies are major drivers of the global arteriovenous malformation market.

    The Americas can dominate the global arteriovenous malformation market due to a large healthcare expenditure and a large patient pool of brain disorders.

    The Middle East & Africa (MEA) can showcase the lowest growth rate in the global arteriovenous malformation market due to lack of funds and limited number of facilities.

    Toshiba Medical Systems Corporation, Fujifilm Holdings, Philips Healthcare, Carestream Health, Esaote, Shimadzu Corporation, Hologic, Masimo Corporation, GE Healthcare, Electrical Geodesics Inc., Siemens Healthcare, and Nihon Kohden Corporation are notable players of the global arteriovenous malformation market.